Kenta Biotech Ltd Report issue

For profit Phase 2
Founded: Zug Switzerland (2006)
Status: Acquired by Aridis Pharmaceuticals, Inc. (2013)

Organization Overview

First Clinical Trial
2008
NCT00851435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

kbpa-101 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Healthcare-Associated Pneumonia (Phase 2)

Pneumonia (Phase 2)

Pneumonia, Ventilator-Associated (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1